844
C. L. Cioffi et al.
LETTER
N-Aryl Imines 3a–i; General Procedure
To an oven-dried round-bottom flask charged with tris(dibenz-
1H NMR (300 MHz, CDCl3): d = 7.79 (m, 1 H), 7.71 (m, 1 H), 7.36
(m, 3 H), 7.24 (m, 2 H), 7.15 (m, 2 H), 7.06 (m, 1 H), 6.53 (m, 1 H),
6.51 (m, 1 H), 2.93 (m, 2 H), 2.41 (m, 2 H).
ylidene)dipalladium(0) [Pd2(dba)3,
1
mol%], racemic-2,2¢-
bis(diphenylphosphino)-1,1¢-binaphthyl (BINAP, 3 mol%), sodium
tert-butoxide (1.4 mmol) and anhyd toluene (2 mL) at r.t. under ni-
trogen were added aryl halide or triflate 1 (1.1 mmol) and the fluor-
ous benzophenone imine reagent 2 (f-BPI, 1.0 mmol) and the
mixture was heated at 80 ºC. When the conversion was judged as
complete (by TLC analysis), the mixture was cooled to r.t. and the
solvent was removed under reduced pressure. The residue was dis-
solved in THF (1 mL) and placed onto a column containing Fluo-
roFlashTM silica gel (5 g), which was pre-treated with a MeOH–
water mixture (4:1, 20 mL). The column was initially flushed with
a MeOH–water mixture (4:1, 30 mL, fluorophobic fraction) to re-
move non-fluorous organic components, followed by elution with
either MeOH or THF (30 mL, fluorophilic fraction). The collected
fluorophilic fraction was concentrated under reduced pressure to
provide the desired imine adducts 3 in >95% purity in all cases. Fi-
13C NMR (300 MHz, CDCl3): d = 23.76, 26.21, 28.99, 67.53,
107.80. 112.74, 113.00, 123.86, 123.96, 124.02, 124.08, 127.98,
128.04, 128.21, 128.70, 128.98, 129.34, 129.46, 130.50.
APCI MS: m/z = 709 [C27H16F17NS + H]+.
Anilines 4a–i; General Procedure
To a solution of the imine adduct 3 in THF (0.3 M solution) at r.t.
was added aqueous 2.0 M HCl solution (approximately 5% by vol-
ume with THF). When the conversion was judged as complete (by
TLC analysis), the mixture was made alkaline by addition of MP-
carbonate resin (150 mg). The mixture was then placed directly onto
a cartridge of FluoroFlashTM silica gel (5 g), which was pretreated
with a MeOH–water mixture (4:1, 20 mL). The column was initially
flushed with a MeOH–water mixture (30 mL, fluorophobic frac-
tion) to collect the organic product, followed by elution with MeOH
or THF (30 mL, fluorophilic fraction) to collect the fluorous ben-
zophenone byproduct. The fluorophobic fraction was concentrated
under reduced pressure to provide the desired aniline free bases 4 in
>95% purity in all cases. The fluorophilic fraction was concentrated
under reduced pressure to provide recovered fluorous benzophe-
none 5. Final products were characterized by APCI MS, 1H NMR
and 13C NMR spectroscopy. The reaction conditions were not opti-
mized, and selected examples are shown.
1
nal products were characterized by APCI MS, H NMR and 13C
NMR spectroscopy. The reaction conditions were not optimized,
and selected examples are shown.
4-({[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorode-
cyl)phenyl]phenylmethylene}amino)benzonitrile (3a)
From 4-bromobenzonitrile (1a, 64 mg, 0.35 mmol); light yellow
gum (200 mg, 86%).
1H NMR (300 MHz, CDCl3): d = 7.80 (m, 2 H), 7.71 (m, 1 H), 7.36
(m, 3 H), 7.24 (m, 2 H), 7.15 (m, 2 H), 7.06 (m, 1 H), 6.55 (m, 2 H),
2.93 (m, 2 H), 2.41 (m, 2 H).
13C NMR (300 MHz, CDCl3): d = 26.77, 33.03, 106.71, 119.59,
121.73, 128.64, 129.57, 130.31, 131.01, 131.76, 133.14, 155.81,
169.39.
4-Aminobenzonitrile (4a)8,9
From 4-{[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-
decyl)phenyl]phenylmethylene}-amino)benzonitrile (3a, 130 mg,
0.18 mmol); yellow oil (20 mg, 95%); mp 84–87 ºC (Lit9a mp 86–
87 ºC).
APCI MS: m/z = 728 [C30H17F17N2 + H]+.
1H NMR (300 MHz, CDCl3): d = 7.42 (d, J = 8.57 Hz, 2 H), 6.65 (d,
J = 8.61 Hz, 2 H), 4.10 (br s, 2 H).
1-[4-({[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-
decyl)phenyl]phenylmethylene}amino)phenyl]ethanone (3c)
From 4¢-bromoacetophenone (1c, 70 mg, 0.35 mmol); yellow gum
(190 mg, 79%).
1H NMR (300 MHz, CDCl3): d = 7.81 (m, 2 H), 7.75 (m, 1 H), 7.40
(m, 3 H), 7.30 (m, 2 H), 7.15 (m, 2 H), 7.06 (m, 1 H), 6.60 (m, 2 H),
2.93 (m, 2 H), 2.53 (s, 3 H), 2.41 (m, 2 H).
13C NMR (300 MHz, CDCl3): d = 26.63, 32.99, 120.97, 127.70,
128.61, 129.67, 130.31, 131.02, 132.62, 132.75, 156.26, 168.72,
197.51.
13C NMR (300 MHz, CDCl3): d = 112.71, 125.66, 151.83.
APCI MS: m/z = 154 [C7H6N2 + H]+.
4¢-Aminoacetophenone (4c)8,11
From 1-[4-({[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecaflu-
orodecyl)phenyl]phenylmethylene}-amino)phenyl]ethanone (3c,
160 mg, 0.22 mmol); white solid (26 mg, 90%); mp 100–102 ºC
(Lit11a mp 104–105 ºC).
1H NMR (300 MHz, CDCl3): d = 7.83 (d, J = 2.48 Hz, 2 H), 6.66 (d,
J = 2.52 Hz, 2 H), 4.11 (br s, 2 H), 2.50 (s, 3 H).
13C NMR (300 MHz, CDCl3): d = 31.97, 34.33, 115.37, 126.46,
141.22, 144.25.
APCI MS: m/z = 136 [C8H9NO + H]+.
APCI MS: m/z = 745 [C31H20F17NO + H]+.
{[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorode-
cyl)phenyl]phenylmethylene}-m-tolylamine (3f)
From 3-iodotoluene (1f, 84 mg, 0.35 mmol); light yellow gum (84
mg, 65%).
1H NMR (300 MHz, CDCl3): d = 7.79 (m, 2 H), 7.71 (m, 1 H), 7.57
(m, 2 H), 7.48 (m, 3 H), 7.33 (m, 1 H), 7.26 (m, 3 H), 7.09 (m, 1 H),
2.98 (m, 2 H), 2.36 (m, 2 H), 2.21 (s, 3 H).
13C NMR (300 MHz, CDCl3): d = 24.26, 26.23, 29.52, 33.12, 68.37,
118.58, 122.54, 124.69, 128.49, 128.62, 128.86, 128.91, 128.99,
129.27, 130.03, 130.17, 130.51, 130.70, 130.79, 131.41.
m-Toluidine (4f)8,14
From {[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorode-
cyl)phenyl]phenylmethylene}-m-tolylamine (3f, 140 mg, 0.20
mmol); yellow oil (18 mg, 88%).
1H NMR (300 MHz, CDCl3): d = 7.03 (m, 1 H), 6.56 (m, 1 H), 6.44
(m, 1 H), 3.49 (br s, 2 H), 2.22 (s, 3 H).
13C NMR (300 MHz, CDCl3): d = 22.46, 113.33, 116.99, 120.42,
130.20, 140.20, 147.55.
APCI MS: m/z = 107 [C7H9N + H]+.
APCI MS: m/z = 717 [C30H20F17N + H]+.
{[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorode-
cyl)phenyl]phenylmethylene}thiophen-3-ylamine (3h)
From 3-bromothiophene (1h, 62 mg, 0.35 mmol); light yellow gum
(220 mg, 97%).
2-Aminothiophene (4h)15
From {[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorode-
cyl)phenyl]phenylmethylene}-thiophen-3-ylamine (3h, 200 mg,
0.28 mmol); white solid (26 mg, 92%); mp 140–145 ºC (Lit15a mp
146 ºC ).
Synlett 2004, No. 5, 841–845 © Thieme Stuttgart · New York